Founder’s perspective: a conversation with Elisa Manzotti on 10 years of Cell & Gene Therapy Insights

Elisa Manzotti

04 November 2025

Interview

Beyond the biologic: rethinking supply chain models for cell and gene therapy

Phillip Ramsey

03 November 2025

Interview

In conversation with Nina Bauer: CAR-T milestones, navigating investment landscapes, and the three Ps of CGT

Nina Bauer

29 October 2025

Interview

In conversation with Yu Cao: engineering tomorrow’s needle-to-cure therapeutics with in vivo CAR-T

Yu Cao

28 October 2025

Interview

In conversation with Alexis Cockroft: driving sustainable, globally accessible cell and gene therapies through regulation

Alexis Cockroft

28 October 2025

Interview

CRISPR in action: inside the first genome-wide NK cell screen and what it means for immunotherapy

Alexander Biederstädt

21 October 2025

Interview

Unpacking the challenges of AAV gene therapy: exploring capsid engineering, immunogenicity management, and scalable manufacturing solutions

Sherif Gabriel

14 October 2025

Interview

Perspectives on quality, compliance, and innovation to accelerate CGT manufacturing

Hélène Negre

19 September 2025

Interview

Beyond CRISPR: TALEN, smart cells, and the regulatory edge in gene editing

David Sourdive

09 September 2025

Interview

Bridging viral immunology and CAR-T therapy: leveraging natural T cell responses to enhance engineered cell therapies

Catherine Bollard

03 September 2025

Interview

Rethinking lentiviral manufacturing for cell and gene therapies: from platform design to point-of-care delivery

Michael Kadan, Boro Dropulić

19 August 2025

Interview

From CRISPR to DNA writing: expanding the gene editing toolbox

Laura Sepp-Lorenzino

21 July 2025

Interview

Bringing cell therapies closer to patients: the role of automation, analytics, and decentralized manufacturing

Therese Choquette

16 July 2025

Interview

Manufacturing and clinical development strategies to expand access to CAR-T cell therapy for patients in India

Amit Mookim

10 July 2025

Interview

Exploring asprosin: how AAV vectors are advancing hormone research

Bijoya Basu

03 July 2025

Interview

Rewriting the code: examining the promise and responsibility of gene editing

Bambi Grilley

02 July 2025

Interview

Exploring the UK’s evolving role in commercializing cell and gene therapies

Matthew Durdy

17 June 2025

Interview

Key considerations for scalable retroviral vector production—with a focus on lentivirus

Alex Chatel

16 June 2025

Interview

Revolutionizing non-viral gene delivery with silicon-stabilized LNPs

Suzanne Saffie-Siebert

20 May 2025

Interview

Optimizing upstream processing to improve consistency and scalability in viral vector production

Katerina Rigaki

19 May 2025

Interview

Exploring innovations in AAV upstream processing to advance gene therapy development

Hao Liu

08 May 2025

Interview